These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26914818)

  • 21. Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy.
    Russell CM; Lebastchi AH; Chipollini J; Niemann A; Mehra R; Morgan TM; Miller DC; Palapattu GS; Hafez KS; Sexton WJ; Spiess PE; Weizer AZ
    Urology; 2018 Jul; 117():95-100. PubMed ID: 29678662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
    Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
    Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis.
    Kim HL; Belldegrun AS; Freitas DG; Bui MH; Han KR; Dorey FJ; Figlin RA
    J Urol; 2003 Nov; 170(5):1742-6. PubMed ID: 14532767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma.
    Parker WP; Lohse CM; Zaid HB; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Urol Oncol; 2017 Jan; 35(1):36.e1-36.e6. PubMed ID: 27687543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Predictor of Survival with Renal Cell Carcinoma After Nephrectomy.
    Peng D; He ZS; Li XS; Tang Q; Zhang L; Yang KW; Yu XT; Zhang CJ; Zhou LQ
    J Endourol; 2017 Apr; 31(4):397-404. PubMed ID: 28121179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
    Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T
    BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative epidural analgesia is not associated with increased survival from renal cell cancer, but overall survival may be improved: a retrospective chart review.
    Kovac E; Firoozbakhsh F; Zargar H; Fergany A; Elsharkawy H
    Can J Anaesth; 2017 Jul; 64(7):754-762. PubMed ID: 28417354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Operative safety and oncologic outcome of laparoscopic radical nephrectomy for renal cell carcinoma >7 cm: a multicenter study of 222 patients.
    Luciani LG; Porpiglia F; Cai T; D'Elia C; Vattovani V; Giusti G; Tiscione D; Chiodini S; Peschechera R; Fiori C; Spina R; Parma P; Celia A; Malossini G
    Urology; 2013 Jun; 81(6):1239-44. PubMed ID: 23608667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
    Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus.
    Cao C; Bi X; Liang J; Li L; Zhang H; Xiao Z; Xiao Z; Tian J; Wang D; Guan K; Li C; Ma J; Zheng S; Shou J
    BMC Cancer; 2019 Feb; 19(1):144. PubMed ID: 30760245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
    Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
    Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
    Soria F; de Martino M; Leitner CV; Moschini M; Shariat SF; Klatte T
    Clin Genitourin Cancer; 2017 Jun; 15(3):e421-e427. PubMed ID: 28089722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma.
    Zganjar A; Khanna A; Joyce D; Nichols P; Britton C; Lohse CM; Cheville JC; Gupta S; Potretzke AM; Thompson RH; Leibovich BC; Boorjian SA; Sharma V
    J Urol; 2024 Aug; 212(2):331-341. PubMed ID: 38813884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
    Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
    Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.
    Chen X; Li S; Xu Z; Wang K; Fu D; Liu Q; Wang X; Wu B
    World J Surg Oncol; 2015 Feb; 13():14. PubMed ID: 25650039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraneoplastic syndromes and oncological outcomes in renal cancer.
    Ikuerowo SO; Ojewuyi OO; Omisanjo OA; Abolarinwa AA; Bioku MJ; Doherty AF
    Niger J Clin Pract; 2019 Sep; 22(9):1271-1275. PubMed ID: 31489865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
    Takagi T; Kondo T; Izuka J; Kobayashi H; Tomita E; Hashimoto Y; Tanabe K
    Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.